171 related articles for article (PubMed ID: 30959357)
1. The role of the P2X7 receptor in myeloid-derived suppressor cells and immunosuppression.
Principi E; Raffaghello L
Curr Opin Pharmacol; 2019 Aug; 47():82-89. PubMed ID: 30959357
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression.
Groth C; Hu X; Weber R; Fleming V; Altevogt P; Utikal J; Umansky V
Br J Cancer; 2019 Jan; 120(1):16-25. PubMed ID: 30413826
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Novel Subset of Myeloid-Derived Suppressor Cells During Chronic Staphylococcal Infection That Resembles Immature Eosinophils.
Goldmann O; Beineke A; Medina E
J Infect Dis; 2017 Dec; 216(11):1444-1451. PubMed ID: 29029332
[TBL] [Abstract][Full Text] [Related]
4. Myeloid-Derived Suppressor Cells: Ductile Targets in Disease.
Consonni FM; Porta C; Marino A; Pandolfo C; Mola S; Bleve A; Sica A
Front Immunol; 2019; 10():949. PubMed ID: 31130949
[TBL] [Abstract][Full Text] [Related]
5. Arginase-1 is neither constitutively expressed in nor required for myeloid-derived suppressor cell-mediated inhibition of T-cell proliferation.
Bian Z; Abdelaal AM; Shi L; Liang H; Xiong L; Kidder K; Venkataramani M; Culpepper C; Zen K; Liu Y
Eur J Immunol; 2018 Jun; 48(6):1046-1058. PubMed ID: 29488625
[TBL] [Abstract][Full Text] [Related]
6. The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative.
Karin N
Front Immunol; 2020; 11():557586. PubMed ID: 33193327
[TBL] [Abstract][Full Text] [Related]
7. Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression.
Fleming V; Hu X; Weber R; Nagibin V; Groth C; Altevogt P; Utikal J; Umansky V
Front Immunol; 2018; 9():398. PubMed ID: 29552012
[TBL] [Abstract][Full Text] [Related]
8. Immature myeloid-derived suppressor cells: A bridge between inflammation and cancer (Review).
Musolino C; Allegra A; Pioggia G; Gangemi S
Oncol Rep; 2017 Feb; 37(2):671-683. PubMed ID: 27922687
[TBL] [Abstract][Full Text] [Related]
9. Tolerogenic Role of Myeloid Suppressor Cells in Organ Transplantation.
Ochando J; Conde P; Utrero-Rico A; Paz-Artal E
Front Immunol; 2019; 10():374. PubMed ID: 30894860
[TBL] [Abstract][Full Text] [Related]
10. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y
Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937
[TBL] [Abstract][Full Text] [Related]
11. Myeloid derived suppressor cells and autoimmunity.
Boros P; Ochando J; Zeher M
Hum Immunol; 2016 Aug; 77(8):631-636. PubMed ID: 27240453
[TBL] [Abstract][Full Text] [Related]
12. How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions.
Bruger AM; Dorhoi A; Esendagli G; Barczyk-Kahlert K; van der Bruggen P; Lipoldova M; Perecko T; Santibanez J; Saraiva M; Van Ginderachter JA; Brandau S
Cancer Immunol Immunother; 2019 Apr; 68(4):631-644. PubMed ID: 29785656
[TBL] [Abstract][Full Text] [Related]
13. Melanoma Extracellular Vesicles Generate Immunosuppressive Myeloid Cells by Upregulating PD-L1 via TLR4 Signaling.
Fleming V; Hu X; Weller C; Weber R; Groth C; Riester Z; Hüser L; Sun Q; Nagibin V; Kirschning C; Bronte V; Utikal J; Altevogt P; Umansky V
Cancer Res; 2019 Sep; 79(18):4715-4728. PubMed ID: 31337655
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-derived suppressor cells (MDSC): When good intentions go awry.
Sanchez-Pino MD; Dean MJ; Ochoa AC
Cell Immunol; 2021 Apr; 362():104302. PubMed ID: 33592540
[TBL] [Abstract][Full Text] [Related]
15. Myeloid suppressor cells in cancer and autoimmunity.
Sica A; Massarotti M
J Autoimmun; 2017 Dec; 85():117-125. PubMed ID: 28728794
[TBL] [Abstract][Full Text] [Related]
16. Plasticity and biological diversity of myeloid derived suppressor cells.
Ben-Meir K; Twaik N; Baniyash M
Curr Opin Immunol; 2018 Apr; 51():154-161. PubMed ID: 29614426
[TBL] [Abstract][Full Text] [Related]
17. The potential therapeutic role of myeloid-derived suppressor cells in autoimmune arthritis.
Wang Y; Tian J; Wang S
Semin Arthritis Rheum; 2016 Feb; 45(4):490-5. PubMed ID: 26272193
[TBL] [Abstract][Full Text] [Related]
18. Myeloid-derived suppressor cells as effectors of immune suppression in cancer.
Pyzer AR; Cole L; Rosenblatt J; Avigan DE
Int J Cancer; 2016 Nov; 139(9):1915-26. PubMed ID: 27299510
[TBL] [Abstract][Full Text] [Related]
19. Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer.
Ma P; Beatty PL; McKolanis J; Brand R; Schoen RE; Finn OJ
Front Immunol; 2019; 10():1401. PubMed ID: 31275327
[TBL] [Abstract][Full Text] [Related]
20. The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis.
Magcwebeba T; Dorhoi A; du Plessis N
Front Immunol; 2019; 10():917. PubMed ID: 31114578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]